Physician profile
Matthew D Gaskill
NPI 1467716159
$14,554.94
in general payments reported to CMS, 2019-2025
26 companies · $2,055 in 2025
The $2,055 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $258 · 2021: $3,279 · 2022: $1,514 · 2023: $5,272 · 2024: $2,176 · 2025: $2,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,876 · Food and Beverage: $4,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,876.07 |
| Food and Beverage | $4,627.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,328.50 | 2020-2025 | Aveir, Jot Dx, Merlin@Home |
| Boston Scientific Corporation | $3,049.59 | 2021-2025 | Watchman Flx, Rhythmia Mapping System, Sq-Rx Pulse Generator |
| Siemens Medical Solutions USA, INC. | $680.15 | 2023 | Artis Icono Biplane, Artis Q.Zen Biplane, Acuson Sc2000 Diagnostic Ultrasound System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $603.99 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $276.42 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $179.31 | 2020-2025 | |
| Philips North America LLC | $166.13 | 2022-2025 | Ecc Solutions, Extended Holter |
| Astrazeneca Pharmaceuticals LP | $143.65 | 2021-2023 | Farxiga, Brilinta |
| Heartflow, INC. | $135.85 | 2022 | |
| Impulse Dynamics (USA) INC. | $112.93 | 2022-2023 | Optimizer |
| Janssen Scientific Affairs, LLC | $101.25 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $98.43 | 2024-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $97.95 | 2023 | Xarelto |
| Recor Medical INC | $65.99 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Pfizer INC. | $54.13 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $52.94 | 2022-2024 | |
| Medtronic, INC. | $46.37 | 2023 | Micra |
| Amgen INC. | $45.38 | 2022-2023 | Repatha |
| Atricure, INC. | $45.31 | 2022 | |
| Merck Sharp & Dohme LLC | $34.76 | 2023 | Verquvo |
| Abiomed | $31.58 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.85 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $17.44 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.87 | 2023 | Evkeeza |
| Elutia, INC. | $9.69 | 2023 | |
| Altathera Pharmaceuticals LLC | $5.89 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gaskill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.